Next-Generation Haematology Analyser Introduced

The Alinity hq analyser for haematology is now CE Marked and available in Europe and other countries that recognise CE Mark. The analyser is the first in the Alinity hematology series of instruments to be commercially released, and is part of the planned integrated haematology system designed to address the productivity needs of the high-volume laboratory. The Alinity hq was built from the ground up to help solve every day operational challenges and anticipated future needs for high-volume laboratories.

Some unique capabilities of the Alinity hq system include: Innovative, advanced optical technology combined with robust algorithms to handle normal and pathological samples. Design features that are intended to reduce manual steps and minimise errors, improve confidence in data and allow for uninterrupted operation and scalable, modular design to customise configurations to better serve a broad spectrum of laboratories.

As part of the Alinity family of harmonized systems, the Alinity hq analyser has an intuitive user interface with iconography, colour coding and reporting features shared by all Alinity instruments. The Alinity family also uses a common method for sample loading and reagent management, which helps laboratories simplify technician training. The Alinity portfolio includes clinical chemistry, immunoassay, blood and plasma screening, point of care, haematology and molecular diagnostics.

Luis de Luzuriaga, Divisional Vice President and General Manager for Abbott’s haematology business, said, “The Alinity hq launch is a key milestone for Abbott’s hematology business unit. Abbott is leading the way to providing a more efficient, complete laboratory solution that no competitor in the industry can match. With the Alinity family of harmonised systems, Abbott aims to simplify diagnostics testing across laboratory disciplines and help our customers improve patient outcomes.”